BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Selphagy Therapeutics

Selphagy Therapeutics logo

United States of America based

The company has already identified molecules it believes can improve the removal of damaged or misfolded proteins that accumulate with aging and lead to diseases such as Alzheimer’s, Parkinson’s, amyloidosis, and other age-related neurodegenerative diseases. These drugs aim to target the autophagy process helping our bodies clean out the cellular garbage and restore homeostasis and function lost due to the aging process.


Aging Research  

R&D Platform


No pipelines published yet




No services posted yet